Hisamitsu Pharmaceutical Co., Inc. is a leading pharmaceutical company based in Japan with a high-risk ESG score of 33.2. The company operates in two main segments - Medical and Related Products, and Others. The Medical segment includes popular brands like Salanpas, Salonsip, Lifecella, Mohrus, and Keplat, offering topical medication solutions such as pain relief creams, gels, sprays, lotions, and ointments. Aside from pharmaceuticals, Hisamitsu also has diversified businesses like cable television broadcasting, internet connection, packing materials, and insurance. With a presence in Japan and North America, Hisamitsu is a key player in the pharmaceutical industry.